8/10, 10:36 PM (Source: TeleTrader)
more TeleTrader news


Chart for: Novavax, Inc.

Novavax's revenue jumps to $35.6M in Q2

Novavax Inc. reported on Monday that its revenue in the second quarter of fiscal 2020 landed at $35.6 million, after a jump of whopping 957.7% compared to the figure of $3.36 million in the same three-month period the year before.

The company reported a net loss of $17.5 million in the quarter ended on June 30, with its diluted loss per share standing at $0.30, compared to the loss per share of $1.69 recorded during the same period the year prior.

Novavax has signed an agreement with the United States government in July and was granted $1.6 billion to both further the development and boost the manufacturing of its COVID-19 vaccine candidate.

Breaking the News / BU